Replies to post #559025 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

This is my concern. Flashworks was acquired in Sept 2020, and nearly two and a half years later it’s still not optimized.

That’s not my definition of a turnkey system.

The complexity is not in the base equipment but in the step by step development work needed to demonstrate its appropriateness for the function and its performance to mfg quality defined product.

[Roman516]

Simplicity with Flaskworks EDEN device.
Interesting points, having studied the Flaskworks patents, hardware, software and overall capability of the Flaskworks EDEN, nothing but genius design and hats off to Shashi Murthy for all his design and development effort. The Flaskworks EDEN device has the capability to increase vaccine production rates by a factor of 10x to 15x over standard manual vaccine processes. The good news is that Flaskworks EDEN device is very adaptive via its hardware and software operational capabilities. In all, extensive testing and analysis has already been conducted and will prove that the Flaskworks EDEN device will support current and future vaccine manufacturing. BTW, the Flaskworks EDEN device is extremely adaptive to be able to address multiple statistical manufacturing issues at a CMMI level-5 performance. Having worked with multiple Regulatory Agencies for over 30+ years, the Flaskworks EDEN device sells itself, and will enable and enhance vaccine production both quantity and quality, IMPO.